Citius Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $1,667 | $3,944 | $0 | $0 |
Gross Profit | -381 | 2,581 | -62 | -41 |
EBITDA | -30,433 | -8,445 | -8,321 | -8,726 |
EBIT | -32,194 | -9,019 | -8,383 | -8,767 |
Net Income | -21,231 | -8,220 | -7,959 | -8,789 |
Net Change In Cash | 1,667 | 3,944 | 0 | 0 |
Free Cash Flow | -1,300 | -13,008 | -11,880 | -5,406 |
Cash | 4,590 | 7,721 | 4,252 | 6,089 |
Basic Shares | 22,376 | 21,495 | 18,067 | 11,006 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -214 | -209 | -194 | -179 |
EBITDA | -38,201 | -38,640 | -31,772 | -32,884 |
EBIT | -38,415 | -38,849 | -31,966 | -33,064 |
Net Income | -37,433 | -39,138 | -32,542 | -33,640 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -28,361 | |||
Free Cash Flow | -26,552 | -28,201 | -29,060 | -28,361 |
Cash | 4,252 | 3,251 | 26,480 | 41,711 |
Basic Shares | 11,065 | 11,590 | 10,086 | 9,738 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.95 |
2025-12-31 | -$0.38 |
2025-09-30 | -$0.11 |
2025-06-30 | -$0.80 |